Response to: Premature ovulation; is any risk small enough to take when avoidable?

dc.creator	Messinis I.E., Messini C.I., Anifandis G., Daponte A.	en
dc.date.accessioned	2023-01-31T08:59:21Z
dc.date.available	2023-01-31T08:59:21Z
dc.date.issued	2021
dc.identifier	10.1016/j.rbmo.2021.07.009
dc.identifier.issn	14726483
dc.identifier.uri	http://hdl.handle.net/11615/76565
dc.description.abstract	[No abstract available]	en
dc.language.iso	en	en
dc.source	Reproductive BioMedicine Online	en
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115121450&doi=10.1016%2fj.rbmo.2021.07.009&partnerID=40&md5=1f4cc8686c3d806f4f8d2fd9347dd441
dc.subject	chorionic gonadotropin	en
dc.subject	gonadorelin derivative	en
dc.subject	human menopausal gonadotropin	en
dc.subject	blood sampling	en
dc.subject	female	en
dc.subject	human	en
dc.subject	in vitro fertilization	en
dc.subject	Letter	en
dc.subject	oocyte	en
dc.subject	oocyte maturation	en
dc.subject	ovary follicle	en
dc.subject	ovulation	en
dc.subject	prematurity	en
dc.subject	risk assessment	en
dc.subject	in vitro fertilization	en
dc.subject	Female	en
dc.subject	Fertilization in Vitro	en
dc.subject	Humans	en
dc.subject	Ovulation	en
dc.subject	Elsevier Ltd	en
dc.title	Response to: Premature ovulation; is any risk small enough to take when avoidable?	en
dc.type	other	en

Αρχεία σε αυτό το τεκμήριο

Αρχεία	Μέγεθος	Τύπος	Προβολή
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.